MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: First Human Implant Of Heartware's HVAD

Back to heart news Blogs list Cancer blog  


Subscribe To Heart News RSS Feed  RSS content feed What is RSS feed?

First Human Implant Of Heartware's Hvad

First Human Implant Of Heartware's HVAD Image courtesy of Heartware
On 22 March 2006, a 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device. The implant was conducted at the Vienna General Hospital and the surgical team was led by Dr Georg Wieselthaler, Clinical Director of Mechanical Circulatory Support at the University of Vienna.

The successful implant marks the start of HeartWare's CE mark clinical study. The trial protocol calls for the implantation of the device in twenty patients suffering advanced heart failure. The implants are to be conducted at the Vienna General Hospital (Austria), the Royal Perth Hospital (Australia), the Hannover Medical Centre (Gera number of) and Harefield Hospital (UK). HeartWare expects to complete patient enrolment in the trial by the end of 2006.

Commenting on the first implant, Dr Wieselthaler said:.

"Our first clinical experience of the HVAD was extremely positive. The procedure was completed quickly and without incident, and our patient's early post-operative recovery has been excellent.

The device's small size and configuration facilitated a relatively fast implant procedure. The surgery took only 85 minutes, significantly less than the time typically mandatory to implant other devices. The patient was moved from the operating theatre into the post operative recovery area, conscious and off ventilation within seven hours. He continues to recover quickly and has met with his family. We are very pleased with these results."

HeartWare CEO, Mr Stuart McConchie, commented from Vienna:.

"The performance of the HVAD continues to support our high expectations for its clinical potential. The early success of this first implant marks the culmination of a number of years of effort in conceiving, designing, developing and testing what we believe to be the world's leading mechanical circulatory assist device.

The HVAD is the smallest 3rd generation circulatory assist device available. It is the only full-output pump implantable in the pericardial space and the only centrifugal pump implantable above the diaphragm. The pump's impeller design, together with its integrated inflow cannula, help to ensure optimal blood flow characteristics which should, over time, allow reduction of the anticoagulant levels typically mandatory for LVAD recipients.

The HVAD's unique design should allow long term device durability - providing the genuine prospect of "lifelong" treatment. We are extremely encouraged by the early results of our first implant and look forward to confirming and replicating these results through the course of the clinical trial. I would especially like to recognise the efforts of the dedicated teams at HeartWare and at Vienna General Hospital who together have made this initial implant possible."



Posted by: Daniel    Source




Did you know?
On 22 March 2006, a 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device. The implant was conducted at the Vienna General Hospital and the surgical team was led by Dr Georg Wieselthaler, Clinical Director of Mechanical Circulatory Support at the University of Vienna.

Medicineworld.org: First Human Implant Of Heartware's HVAD

Aggressive heart therapies still underused| Aspirin might prevent vioxx cardiac damage| Bariatric surgery to control weight in cardiac patients| Black immigrants from africa arrive healthier than those from europe| Exercise stress management gives physiological benefits for heart patients| Heart and cell signaling| Link between obesity inflammation and vascular disease found| Pig hearts in nonhuman primates a success story| Strategies to raise hdl cholesterol levels| Stress test identifies high risk people for coronory heart disease|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.